Related references
Note: Only part of the references are listed.Association of HPV35 with cervical carcinogenesis among women of African ancestry: Evidence of viral-host interaction with implications for disease intervention
Maisa Pinheiro et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programs
Maria Demarco et al.
ECLINICALMEDICINE (2020)
Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines
Didem Egemen et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2020)
2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors
Rebecca B. Perkins et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2020)
Changes in DNA Level of Oncogenic Human Papillomaviruses Other Than Types 16 and 18 in Relation to Risk of Cervical Intraepithelial Neoplasia Grades 2 and 3
Long Fu Xi et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2019)
Clinical Evaluation of Human Papillomavirus Screening With p16/Ki-67 Dual Stain Triage in a Large Organized Cervical Cancer Screening Program
Nicolas Wentzensen et al.
JAMA INTERNAL MEDICINE (2019)
Longitudinal Clinical Performance of the RNA-Based Aptima Human Papillomavirus (AHPV) Assay in Comparison to the DNA-Based Hybrid Capture 2 HPV Test in Two Consecutive Screening Rounds with a 6-Year Interval in Germany
Thomas Iftner et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2019)
Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial
Nicole J. Polman et al.
LANCET ONCOLOGY (2019)
Triage of HPV positive women in cervical cancer screening
Nicolas Wentzensen et al.
JOURNAL OF CLINICAL VIROLOGY (2016)
Carcinogenic human papillomavirus infection
Mark Schiffman et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
Guglielmo Ronco et al.
LANCET (2014)
Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis
Marc Arbyn et al.
LANCET ONCOLOGY (2014)
A Long-term Prospective Study of Type-Specific Human Papillomavirus Infection and Risk of Cervical Neoplasia Among 20,000 Women in the Portland Kaiser Cohort Study
Mark Schiffman et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Persistence of Type-Specific Human Papillomavirus Infection and Increased Long-term Risk of Cervical Cancer
Hui-Chi Chen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Share Paper
